pharmachologic effect Pharmacological action - anti-inflammatory, prostatotropic. Pharmacodynamics Vitaprost has an organotropic effect on the prostate gland. Reduces the degree of edema, leukocyte infiltration of the prostate gland, normalizes the secretory function of epithelial cells, increases the number of lecithin grains in the secretion of the acini, stimulates the muscle tone of the bladder, improves microcirculation in the prostate gland by reducing thrombus formation, antiplatelet activity, prevents the development of prostate venules thrombosis. Vitaprost reduces pain and discomfort, eliminates dysuric phenomena, improves copulatory function, normalizes the parameters of the prostate gland and ejaculate. Based on the data of clinical studies, it has been proven that Vitaprost in the form of enteric-coated tablets moderately reduces the volume of the prostate gland. The drug reduces the severity of obstructive and irritative symptoms in benign prostatic hyperplasia, which is expressed in an increase in the maximum and average volumetric flow rates of urine and a decrease in the volume of residual urine. The data of clinical studies have shown that the use of Vitaprost in the form of enteric-coated tablets reduces the likelihood of exacerbations of chronic abacterial prostatitis, does not cause changes in the indicators of clinical and biochemical blood tests, general urine analysis. The effectiveness of using the drug for the prevention of exacerbations of chronic abacterial prostatitis, according to the estimates of medical researchers, is 97.5%. Indications - Chronic prostatitis; - Conditions before and after surgery on the prostate gland. Method of administration and dosage Rectally, 1 suppository after spontaneous bowel movement or enema 1 time per day. After the administration of the suppository, it is desirable for the patient to stay in bed for 30-40 minutes. The duration of the course of treatment with Vitaprost is at least 10 days. Side effects Extremely rare - allergic reactions. Contraindications Hypersensitivity to the components of the drug. Overdose No cases of drug overdose have been reported. special instructions Influence on the ability to drive vehicles and work with mechanisms: The drug does not affect the ability to perform potentially hazardous activities that require increased concentration of attention and speed of psychomotor reactions (including driving, working with moving mechanisms). Interaction with other drugs Cases of interaction or incompatibility with other drugs are not described. Structure One suppository contains: Active substance: Prostate extract - 50 mg, in terms of water-soluble peptides - 10 mg; Suppository Basics: Solid fat (Witepsol, brands H 15, W 35, Supposir, brands NA 15, NAS 50) - a sufficient amount to obtain a suppository weighing 1.25 g. Storage conditions Keep out of the reach of children, at a temperature not exceeding +20 C. Shelf life is 2 years. Do not use the drug after the expiration date.